GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » LSL Pharma Group Inc (TSXV:LSL) » Definitions » Market Cap

LSL Pharma Group (TSXV:LSL) Market Cap : C$54.00 Mil (As of May. 26, 2024)


View and export this data going back to 2023. Start your Free Trial

What is LSL Pharma Group Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). LSL Pharma Group's share price for the quarter that ended in Dec. 2023 was C$0.485. LSL Pharma Group's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 82.44 Mil. Therefore, LSL Pharma Group's market cap for the quarter that ended in Dec. 2023 was C$39.98 Mil.

LSL Pharma Group's quarterly market cap increased from Jun. 2023 (C$35.45 Mil) to Sep. 2023 (C$39.57 Mil) and increased from Sep. 2023 (C$39.57 Mil) to Dec. 2023 (C$39.98 Mil).

LSL Pharma Group's annual market cap stayed the same from Dec. 2021 (C$0.00 Mil) to Dec. 2022 (C$0.00 Mil) but then increased from Dec. 2022 (C$0.00 Mil) to Dec. 2023 (C$39.98 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. LSL Pharma Group's Enterprise Value for Today is C$70.26 Mil.


LSL Pharma Group Market Cap Historical Data

The historical data trend for LSL Pharma Group's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LSL Pharma Group Market Cap Chart

LSL Pharma Group Annual Data
Trend Sep20 Dec21 Dec22 Dec23
Market Cap
- - - 39.98

LSL Pharma Group Quarterly Data
Sep20 Dec20 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 60.18 35.45 39.57 39.98

Competitive Comparison of LSL Pharma Group's Market Cap

For the Drug Manufacturers - Specialty & Generic subindustry, LSL Pharma Group's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


LSL Pharma Group's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, LSL Pharma Group's Market Cap distribution charts can be found below:

* The bar in red indicates where LSL Pharma Group's Market Cap falls into.



LSL Pharma Group Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

LSL Pharma Group's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=C$0.485*82.4352
=C$39.98

LSL Pharma Group's Market Cap for the quarter that ended in Dec. 2023 is calculated as

Market Cap (Q: Dec. 2023 )=Share Price (Q: Dec. 2023 )*Shares Outstanding (EOP) (Q: Dec. 2023 )
=C$0.485*82.4352
=C$39.98

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


LSL Pharma Group  (TSXV:LSL) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


LSL Pharma Group Market Cap Related Terms

Thank you for viewing the detailed overview of LSL Pharma Group's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


LSL Pharma Group (TSXV:LSL) Business Description

Traded in Other Exchanges
N/A
Address
3030, Le Carrefour Boulevard, Suite 1002, Laval, QC, CAN, H7T 2P5
Website
LSL Pharma Group Inc integrated pharmaceutical company specializing in the development, manufacture and distribution of high-quality natural health products and dietary supplements in solid dosage forms as well as high quality sterile ophthalmic pharmaceutical products.

LSL Pharma Group (TSXV:LSL) Headlines

No Headlines